investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Developing Selective EphA2 Inhibitors for the Treatment of Cancer
Nathanael S Gray
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Nathanael S Gray
Dana-Farber Cancer Institute
Boston, United States
Subrahmanyam Vangala
Sai Advantium Pharma Ltd.
Pune, India
Related projects
Baum S Jean
NMR studies of collagen model peptides and their interactions with collagen recep
Melanoma of skin
Dipak Panigrahy
Control of Cancer and Metastasis by Endothelial-Derived Epoxyeicosatrienoic Acids
Breast
Zhiyuan Shen
Alternative Mechanisms to Inactivate p53 during Oncogenesis
Breast
Alana L Welm
Short-form Ron Kinase in Tumor Progression and Metastasis
Breast
Ann Richmond
Chemokine Signals in the Premetastatic Niche Inhibit Metastasis
Breast
Pasi A Janne
Targeting ALK and ROS1 in Lung Cancer
Trachea, bronchus and lung
Louis Hodgson
Rac1 regulates protrusion and invasion of breast cancers in 3D
Breast
Eric Alejandro Sweet-Cordero
Novel effectors of Kras in oncogenesis, senescence and tumor progression
Trachea, bronchus and lung
Huiyan Zeng
Down Syndrome Candidate Region 1 isoform 1L in tumor growth and metastasis
Melanoma of skin